Search the Newsreel

ACB Stock Alert: What to Know as Curaleaf Announces Takeover Bid for Aurora Cannabis

Aurora Cannabis (ACB) Q1 2027 Earnings Call Transcript

Image source: The Motley Fool. DATE Wednesday, Aug. 5, 2026 at 8:00 a.m. ET CALL PARTICIPANTS Executive Chairman and Chief Executive Officer - Miguel Martin Chief Financial Officer - Simona King Director of Strategic Finance and Investor Relations - Kevin Niland Full Conference Call …

Curaleaf to take offer directly to shareholders in bid to buy Edmonton-based Aurora Cannabis

Curaleaf Holdings Inc. is making a direct appeal to Aurora Cannabis shareholders after its acquisition attempts were rebuffed by Aurora's board. Curaleaf is proposing to pay $4 US per share plus $0.75 US cash for each Aurora share, a move Aurora's board has resisted, …

Aurora Cannabis to Review Takeover Bid From Rival Curaleaf

Aurora Cannabis is reviewing an unsolicited takeover bid from rival cannabis company Curaleaf Holdings worth approximately $272 million, or $4 per share. Aurora announced that it received letters from Curaleaf in late June and early July outlining the potential deal and plans to form …

Aurora Cannabis (ACB) Stock Soars Over 20% on a Proposed Takeover Bid from Curaleaf (CURLF)

Aurora Cannabis (ACB) stock surged over 20% following a proposed takeover bid from Curaleaf (CURLF). Curaleaf's offer values ACB stock at $4 per share, representing a 45% premium, and aims to combine operations across 17 countries, generating over $1.5 billion in revenue and creating …

US marijuana MSO Curaleaf plots $272 million hostile takeover of Aurora Cannabis

US-based cannabis multistate operator Curaleaf Holdings is pursuing a hostile takeover of Canadian licensed producer Aurora Cannabis, offering $4 per share in a mix of stock and cash, totaling $272 million. This move comes after Aurora's leadership reportedly declined to discuss a deal, prompting …

Curaleaf Announces Intention to Launch Take-Over Bid for Aurora Cannabis to Solidify its Position as the Global Cannabis Industry Leader

Curaleaf Holdings, Inc. announced its intention to launch a take-over bid for Aurora Cannabis Inc. The proposed offer values Aurora shares at US$4.00, representing a 45% premium over its 30-day Volume Weighted Average Price. Curaleaf aims to create the leading global cannabis platform by …

Aurora Cannabis jumps after Curaleaf says it will make a takeover offer (update) (ACB:NASDAQ)

Aurora Cannabis (ACB) stock surged 21% following an announcement from Curaleaf Holdings (CURLF) about its plan to make a $4 per share takeover bid. The offer, which includes both cash and Curaleaf shares, represents a premium over Aurora's recent trading prices. Aurora Cannabis has …

Curaleaf looks to buy Aurora Cannabis, takes bid directly to shareholders

Curaleaf Holdings Inc. announced its intention to launch a takeover bid for Edmonton-based Aurora Cannabis Inc. after private negotiation attempts failed. Curaleaf plans to offer US$4.00 per share plus US$0.75 cash for each Aurora share, a proposal that analysts believe undervalues Aurora's long-term potential. …

Canadian Stock Movers for Tuesday | Aurora Cannabis Inc Was the Top Gainer; Beverages - Non-Alcoholic Led Gains

Aurora Cannabis Inc. stock falls Monday, underperforms market

Aurora Cannabis Inc. (ACB) shares fell by 3.34% to $2.89 on Monday, underperforming the broader market. The NASDAQ Composite Index and Dow Jones Industrial Average also experienced declines, falling 0.32% and 0.11% respectively. This drop ended a three-day winning streak for Aurora Cannabis Inc.

Aurora Cannabis Shareholders Back Board Slate, Auditor and Say-on-Pay at August AGM

Aurora Cannabis shareholders approved all governance resolutions at their August 7, 2026, annual general meeting, including fixing the board size at five directors, reappointing Ernst & Young, and endorsing executive compensation. Director nominees, including CEO Miguel Martin, received strong majority support, with votes generally …

Stocks in play: Aurora Cannabis Inc.

Aurora Cannabis Inc. announced the voting results from its Annual General Meeting of Shareholders, held virtually on August 7. The company's shares were trading down at $4.09. The article also briefly mentions other investment-related topics such as gold prices and quantum computing.

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Key Takeaways; Cannabis Sector Canopy Growth Posted 13% Revenue Growth as Losses Narrowed Sharply in Q1 FY2027 Aurora Cannabis Narrowed Q1 Loss as International Medical Cannabis Growth Gained Ground Cronos Group Reported Record Q2 Revenue as Profitability and EBITDA Surged Key Takeaways; Psychedelic Sector …

Aurora Cannabis Inc. 2027 Q1 - Results - Earnings Call Presentation (TSX:ACB:CA) 2026-08-08

Image source: The Motley Fool. DATE Wednesday, Aug. 5, 2026 at 8:00 a.m. ET CALL PARTICIPANTS Executive Chairman and Chief Executive Officer - Miguel Martin Chief Financial Officer - Simona King Director of Strategic Finance and Investor Relations - Kevin Niland Full Conference Call …

Why Aurora Cannabis Looks Cheaper Than Its International Growth Suggests – Quarterly Update Report

Download the Complete Report Here Aurora Cannabis Inc. (ACB) International Medical Growth Absorbs Much of Canadian Pricing Reset; Safari and Germany Momentum Strengthen the Medium-Term Growth Outlook. Attractively Valued. Key Takeaways: International medical cannabis revenue increased 17% to C$43.3 million in 1Q FY27, reinforcing …

Aurora Cannabis (NASDAQ:ACB) Upgraded by BMO Capital Markets to Hold Rating

BMO Capital Markets has upgraded Aurora Cannabis (NASDAQ:ACB) to a "hold" rating. The company recently reported quarterly EPS of $0.07, exceeding expectations for a $0.07 loss, and revenue of $60.98 million, surpassing the $54.42 million consensus estimate, though it remained unprofitable. Aurora Cannabis currently …

Aurora Cannabis Shareholders Approve Board as Fiscal 2026 Results Beat Outlook

Aurora Cannabis Inc (ACB) Earnings Forecast: Future EPS & Revenue Growth Estimates

Aurora Cannabis (TSX:ACB) Stock Chases Medical Growth While Cash Flow Lags

Aurora Cannabis Inc (ACB) (Q1 2027) Earnings Call Highlights: International Strength Drives ...

Aurora Cannabis Inc. reported Q1 fiscal 2027 net revenue of CAD67.6 million, largely driven by a 17% increase in international medical cannabis revenue, especially from Germany. Despite a strong adjusted gross margin of 58% and a robust balance sheet with nearly CAD150 million in …

Earnings call transcript: Aurora Cannabis Q1 2027 profit falls as global sales grow

Aurora Cannabis reported a decline in Q1 2027 adjusted EBITDA and negative free cash flow, despite a 17% increase in international medical cannabis revenue, which now accounts for 64% of total net revenue. The company is strategically shifting focus to higher-margin international medical cannabis …

Earnings Flash (ACB) Aurora Cannabis Inc. Reports Q1 Revenue C$67.6M, Vs. FactSet Est of C$67.4M

Aurora Cannabis Inc. (ACB) announced its Q1 revenue reached C$67.6 million, surpassing the FactSet estimate of C$67.4 million. This indicates a slight beat on analyst expectations for the quarter.

Aurora Cannabis Inc. stock rises Wednesday, outperforms market

Aurora Cannabis Inc. (ACB) saw its stock rise by 3.56% on Wednesday, closing at $2.91. This performance outpaced the broader market, as the Dow Jones Industrial Average gained 0.49% while the NASDAQ Composite Index fell 0.83%. Despite the daily gain, the company's stock remains …

Aurora Cannabis Inc reports results for the quarter ended June 30 - Earnings Summary

Aurora Cannabis Inc. has reported its financial results for the quarter that ended on June 30. The article, sourced from Reuters via TradingView News, provides an earnings summary for the company. Readers can access the full report through TradingView's news platform.

Aurora Sees Lower Losses in Q1 2027 as International Growth Offsets Domestic Decline

Aurora Cannabis Inc. reported lower net losses of $4 million in Q1 FY2027, despite a 9% year-over-year decline in net revenue to $67.6 million. This reduction in losses was primarily driven by strong international medical cannabis sales, which grew by 17% to $43.3 million, …

Aurora Cannabis Inc.

Aurora Cannabis Inc. announced its financial and operational results for the first quarter of 2027, which ended on June 30, 2026. Following this announcement, shares of Aurora Cannabis Inc. (T.ACB) saw a modest increase, trading up $0.03 at $3.94. This news provides investors with …

Aurora Cannabis Inc. (ACB) Q1 Earnings and Revenues Beat Estimates

Aurora Cannabis Inc. (ACB) reported Q1 earnings of $0.04 per share, significantly surpassing the Zacks Consensus Estimate of a loss of $0.13 per share and beating revenue expectations. The company has consistently exceeded EPS and revenue estimates over the past year. Despite the positive …

Aurora Cannabis stock gains after Q1 results (ACB:NASDAQ)

ACB: International medical cannabis growth offsets Canadian declines; margins and EBITDA down, but outlook positive

Aurora Cannabis Announces Fiscal 2027 First Quarter Results

Aurora Cannabis Inc. reported its fiscal first quarter 2027 results, showing net revenue of $67.6 million and a 17% year-over-year increase in international medical cannabis net revenue. The company maintains a strong balance sheet with $149.1 million in cash and no debt, and recently …

Aurora Cannabis Q1 Preview: What to expect (ACB:NASDAQ)

Aurora Cannabis (NASDAQ:ACB) in Focus as Cannabis Sentiment Shifts

Aurora Cannabis (NASDAQ:ACB) is gaining attention as the cannabis sector experiences a shift in sentiment, driven by evolving regulatory discussions and a strong focus on medical applications. The company is highlighted for its established presence in the medical cannabis segment across various international markets. …